Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fludarabine
Chronic Obstructive Pulmonary Disease
Paul Szabolcs
P1/2
CCC
(48)
Fludarabine
Ganglioneuroblastoma
Beijing Biotech
P1/2
CCC
(48)
Fludarabine
Gastroesophageal Junction Adenocarcinoma
Beijing Biotech
P1/2
CCC
(48)
Fludarabine
Cervical Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.
P1/2
CCC
(48)
Fludarabine
Vaginal Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.
P1/2
CCC
(48)
Fludarabine
Lung Large Cell Carcinoma
Intima Bioscience, Inc.
P1/2
CCC
(48)
Fludarabine
Malignant Pleural Mesothelioma
Beijing Biotech
P1/2
CCC
(48)
Fludarabine
Peritoneal Mesothelioma
TCR2 Therapeutics
P1/2
CCC
(48)
Fludarabine
Pleural Mesothelioma
TCR2 Therapeutics
P1/2
CCC
(48)
Fludarabine
Ovarian Adenocarcinoma
TCR2 Therapeutics
P1/2
CCC
(48)
Fludarabine
Ovarian Neoplasm
National Cancer Institute (NCI)
P1/2
CCC
(48)
Fludarabine
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
FLUDEOXYGLUCOSE
Atypical Teratoid Rhabdoid Tumor
National Cancer Institute (NCI)
P1/2
CCC
(48)
FLUDEOXYGLUCOSE
Epithelioid Sarcoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
FLUDEOXYGLUCOSE
Kidney Medullary Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
FLUDEOXYGLUCOSE
Poorly Differentiated Chordoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
FLUDEOXYGLUCOSE
Chordoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
FLUDEOXYGLUCOSE
Rhabdoid Tumor
National Cancer Institute (NCI)
P1/2
CCC
(48)
Fog-001
Adamantinous Craniopharyngioma
Parabilis Medicines, Inc.
P1/2
CCC
(48)
Fog-001
Desmoid Tumor
Parabilis Medicines, Inc.
P1/2
CCC
(48)
Fog-001
Endometrial Carcinoma
Parabilis Medicines, Inc.
P1/2
CCC
(48)
fp-045
Fanconi Anemia
Foresee Pharmaceuticals Co., Ltd.
P1/2
CCC
(48)
Fractalkine Receptor Antagonist KAND567
Peritoneum Cancer
Novakand Pharma AB
P1/2
CCC
(48)
Fruquintinib
Small Intestine Cancer
Immunitas Therapeutics
P1/2
CCC
(48)
FULVESTRANT
Squamous Cell Lung Carcinoma
Terremoto Biosciences Inc.
P1/2
CCC
(48)
Showing 1201 to 1225 of 6,308 assets
Previous
Page 49 of 253
Next